EUVIMEDEUVIMED entdecken
Crossref

The Potentially Significant Role of CYP3A-Mediated Oxidative Metabolism of Dabigatran Etexilate and Its Intermediate Metabolites in Drug-Drug Interaction Assessments Using Microdose Dabigatran Etexilate

Udomsak Udomnilobol iD, Suree Jianmongkol iD, Thomayant Prueksaritanont

Drug Metabolism and Disposition · 2023

DOI: 10.1124/dmd.123.001353 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2023. Verfasst von Udomsak Udomnilobol und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Physiology, Faculty of Pharmaceutical Sciences (U.U., S.J.) and Chulalongkorn University Drug Discovery and Drug Devel…. Hauptthemen laut MEDLINE: Dabigatran, Prodrugs. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DabigatranProdrugsHumansCytochrome P-450 CYP3ANADPDrug InteractionsATP Binding Cassette Transporter, Subfamily B, Member 1ATP Binding Cassette Transporter, Subfamily BCytochrome P-450 CYP3A InhibitorsOxidative Stress

Substanzen

DabigatranCytochrome P-450 CYP3AProdrugsNADPATP Binding Cassette Transporter, Subfamily B, Member 1ATP Binding Cassette Transporter, Subfamily BCytochrome P-450 CYP3A Inhibitors

Autor:innen und Institutionen

  • Department of Pharmacology and Physiology, Faculty of Pharmaceutical Sciences (U.U., S.J.) and Chulalongkorn University Drug Discovery and Drug Development Research Center (Chula4DR) (U.U., T.P.), Chulalongkorn Universi…

ORCID-Profile: Udomsak Udomnilobol, Suree Jianmongkol

Zitieren

APA

Udomnilobol, U., Jianmongkol, S., & Prueksaritanont, T. (2023). The Potentially Significant Role of CYP3A-Mediated Oxidative Metabolism of Dabigatran Etexilate and Its Intermediate Metabolites in Drug-Drug Interaction Assessments Using Microdose Dabigatran Etexilate. Drug Metabolism and Disposition. https://doi.org/10.1124/dmd.123.001353

Vancouver

Udomnilobol U, Jianmongkol S, Prueksaritanont T. The Potentially Significant Role of CYP3A-Mediated Oxidative Metabolism of Dabigatran Etexilate and Its Intermediate Metabolites in Drug-Drug Interaction Assessments Using Microdose Dabigatran Etexilate. Drug Metabolism and Disposition. 2023. doi:10.1124/dmd.123.001353

BibTeX
@article{Udomnilobol2023,
  author = {Udomnilobol, Udomsak and Jianmongkol, Suree and Prueksaritanont, Thomayant},
  title = {The Potentially Significant Role of CYP3A-Mediated Oxidative Metabolism of Dabigatran Etexilate and Its Intermediate Metabolites in Drug-Drug Interaction Assessments Using Microdose Dabigatran Etexilate},
  journal = {Drug Metabolism and Disposition},
  year = {2023},
  doi = {10.1124/dmd.123.001353}
}
Kostenlos starten →